Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Urinary Bladder Neoplasms 16Urethral Neoplasms 4Prostatic Neoplasms 4Testicular Neoplasms 3Testicular Germ Cell Tumor 2Teratoma 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Urothelial Carcinoma of the Bladder 1Ureteral Neoplasms 1Seminoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neoplasm Metastasis 1Muscle Invasive Bladder Urothelial Carcinoma 1Endodermal Sinus Tumor 1Carcinoma, Transitional Cell 1Carcinoma, Embryonal 1Bladder Adenocarcinoma 1

Interventions

pembrolizumab 36Carboplatin 28Paclitaxel 23Filgrastim 17Nivolumab 14Gemcitabine 14Cyclophosphamide 14Ifosfamide 13Cisplatin 13Docetaxel 12Specimen Handling 11Etoposide 11olaparib 9Peripheral Blood Stem Cell Transplantation 9Magnetic Resonance Spectroscopy 8fludarabine 6Temozolomide 6Ipilimumab 6Fluorouracil 6Biopsy 6Albumin-Bound Paclitaxel 6rucaparib 5avelumab 5atezolizumab 5Trastuzumab 5Thiotepa 5Taxes 5Standard of Care 5palbociclib 4durvalumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Vinblastine × Genitourinary × Clear all
NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
105 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡